Through the promotion of γδ CD73+ T cells, tumor cells hinder the activity of immune effector cells and the maintenance of the cancer–immunity cycle, as the tumor cells killed through ICD act as essential fuel for this cycle [57]. This evidence concerns the gene NT5E and cancer.